Tiaojing Zhitong Tablets
Natural health product licensed in Canada
- Other names
- Tiaojing Zhitong Pian
- Licence holder
- 11741217 Canada Inc.
- NPN or DIN-HM
- 80137193
- Status
- Active licence
- Licence date
- 17 December 2024
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Cyperus rotundus L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes et allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Codonopsis pilosula Source : Codonopsis pilosula - racine Extract : Matériel brut sec Extraction ratio : 4.784:1 Dry plant equivalent : 203.8 mg | 42.6 mg | Not calculated |
| Angelica sinensis Source : Angelica sinensis - Racine Extract : Matériel brut sec Extraction ratio : 4.784:1 Dry plant equivalent : 306.18 mg | 64 mg | Not calculated |
| Salvia miltiorrhiza Source : Salvia miltiorrhiza - racine et rhizome Extract : Matériel brut sec Extraction ratio : 4.784:1 Dry plant equivalent : 203.8 mg | 42.6 mg | Not calculated |
| Cyperus rotundus | 70.4 mg | Not calculated |
| Leonurus japonicus Source : Leonurus japonicus - Herb Extract : Matériel brut sec Extraction ratio : 4.784:1 Dry plant equivalent : 203.8 mg | 42.6 mg | Not calculated |
| Lycopus lucidus var. hirtus | 70.4 mg | Not calculated |
| Ligusticum sinense cv. chuanxiong Source : Ligusticum sinense cv. chuanxiong - Rhizome | 70.4 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Sucrose, Talcum, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 6 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Remedy/Product/Preparation based on the theory of Traditional Chinese Medicine. Used in TCM to tonify qi, activate blood, regulate menstruation, and relieve pain. Used in TCM for menstrual irregularities, dysmenorrhea, and persistent flow of the lochia after parturition due to qi deficiency with blood stasis, manifested as delayed, scanty menstruation with blood clots, dysmenorrhea, and persistent flow of the lochia after parturition.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80137193
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.